{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:28:21Z","timestamp":1787020101086,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T00:00:00Z","timestamp":1610236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T00:00:00Z","timestamp":1610236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471765"],"award-info":[{"award-number":["81471765"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771950"],"award-info":[{"award-number":["81771950"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To evaluate the efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) on hepatic sinusoidal obstruction syndrome (HSOS) associated with consumption of Gynura segetum (GS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed 9 consecutive patients with GS-related HSOS who were refractory to supportive treatment and underwent TIPS at our institution between January 2014 and September 2019. The patients were evaluated for safety and efficacy, including TIPS complications and changes in portosystemic pressure gradient (PPG), ascites, total bilirubin, liver size and portal vein diameter.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      TIPS procedures were performed successfully in the 9 patients, and no technically-related complications due to the TIPS procedure were recorded. The PPG was improved by TIPS in all patients (mean PPG before TIPS, 30.4\u2009\u00b1\u20095.2 vs. 13.0\u2009\u00b1\u20094.1\u00a0mm Hg post-TIPS,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.008). One patient who was lost to follow-up, whereas the remaining 8 patients survived with a median follow-up period of 12\u00a0months (range 5\u201339\u00a0months). Although the total bilirubin was significantly increased 5\u20137\u00a0days after TIPS compared with that before the procedure (3.57\u2009\u00b1\u20091.58 vs. 4.82\u2009\u00b1\u20092.06\u00a0mg\/dl,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.017), it returned to baseline levels at 1-month follow-up (3.53\u2009\u00b1\u20092.72 vs. 4.82\u2009\u00b1\u20092.06\u00a0mg\/dl,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.401). The patients experienced complete resolution or noticeable reduction of ascites (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), significant reduction of liver size (16.7\u2009\u00b1\u20092.2 vs. 13.7\u2009\u00b1\u20091.7\u00a0cm,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.018), and significant enlargement of the portal trunk (10.7\u2009\u00b1\u20092.5 vs. 13.4\u2009\u00b1\u20092.4\u00a0mm,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.017) after TIPS compared to the pre-TIPS state.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TIPS may offer a potentially useful treatment for the GS-related HSOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-021-01599-7","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T12:02:42Z","timestamp":1610280162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Transjugular intrahepatic portosystemic shunt for hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum"],"prefix":"10.1186","volume":"21","author":[{"given":"Lijie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyman","family":"Makamure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuansheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6130-8629","authenticated-orcid":false,"given":"Bin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,10]]},"reference":[{"key":"1599_CR1","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1182\/blood-2016-02-694943","volume":"127","author":"S Arai","year":"2016","unstructured":"Arai S. Long-awaited news for hepatic veno-occlusive disease. Blood. 2016;127:1630\u20131.","journal-title":"Blood"},{"key":"1599_CR2","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/hep.1840190515","volume":"19","author":"HM Shulman","year":"1994","unstructured":"Shulman HM, Fisher LB, Schoch HG, Henne KW, McDonald GB. Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology. 1994;19:1171\u201381.","journal-title":"Hepatology"},{"key":"1599_CR3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/bmt.2015.52","volume":"50","author":"M Mohty","year":"2015","unstructured":"Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, et al. Sinusoidal obstruction syndrome\/veno-occlusive disease: current situation and perspectives\u2014a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2015;50:781\u20139.","journal-title":"Bone Marrow Transplant"},{"key":"1599_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2036.2006.02742.x","volume":"23","author":"A Helmy","year":"2006","unstructured":"Helmy A. Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. Aliment Pharmacol Ther. 2006;23:11\u201325.","journal-title":"Aliment Pharmacol Ther"},{"key":"1599_CR5","first-page":"330","volume":"24","author":"Y Cheng","year":"2001","unstructured":"Cheng Y, Liang D, Zhan Y. Morphological and histological studies of herba sedum aizoon. Zhong Yao Cai. 2001;24:330\u20132.","journal-title":"Zhong Yao Cai"},{"key":"1599_CR6","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jhep.2010.07.031","volume":"54","author":"G Lin","year":"2011","unstructured":"Lin G, Wang JY, Li N, Li M, Gao H, Ji Y, et al. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J Hepatol. 2011;54:666\u201373.","journal-title":"J Hepatol"},{"key":"1599_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/1751-2980.12112","volume":"15","author":"JY Wang","year":"2014","unstructured":"Wang JY, Gao H. Tusanqi and hepatic sinusoidal obstruction syndrome. J Dig Dis. 2014;15:105\u20137.","journal-title":"J Dig Dis"},{"key":"1599_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12876-018-0879-7","volume":"18","author":"Y Wang","year":"2018","unstructured":"Wang Y, Qiao D, Li Y, Xu F. Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: a retrospective study. BMC Gastroenterol. 2018;18:156.","journal-title":"BMC Gastroenterol"},{"key":"1599_CR9","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1111\/liv.13684","volume":"38","author":"YZ Zhuge","year":"2018","unstructured":"Zhuge YZ, Wang Y, Zhang F, Zhu CK, Zhang W, Zhang M, et al. Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease. Liver Int. 2018;38:1867\u201374.","journal-title":"Liver Int"},{"key":"1599_CR10","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jceh.2014.10.002","volume":"4","author":"CQ Fan","year":"2014","unstructured":"Fan CQ, Crawford JM. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). J Clin Exp Hepatol. 2014;4:332\u201346.","journal-title":"J Clin Exp Hepatol"},{"key":"1599_CR11","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/j.1440-1746.2005.03878.x","volume":"20","author":"MS Khuroo","year":"2005","unstructured":"Khuroo MS, Al-Suhabani H, Al-Sebayel M, Al Ashgar H, Dahab S, Khan MQ, et al. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol. 2005;20:1494\u2013502.","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"1599_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40265-018-1018-z","volume":"79","author":"K Weissenborn","year":"2019","unstructured":"Weissenborn K. Hepatic encephalopathy: definition, clinical grading and diagnostic principles. Drugs. 2019;79(Suppl 1):5\u20139.","journal-title":"Drugs"},{"key":"1599_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jvir.2015.09.018","volume":"27","author":"SR Dariushnia","year":"2016","unstructured":"Dariushnia SR, Haskal ZJ, Midia M, Martin LG, Walker TG, Kalva SP, et al. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol. 2016;27:1\u20137.","journal-title":"J Vasc Interv Radiol"},{"key":"1599_CR14","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00270-012-0493-y","volume":"35","author":"A Krajina","year":"2012","unstructured":"Krajina A, Hulek P, Fejfar T, Valek V. Quality improvement guidelines for transjugular intrahepatic portosystemic shunt (TIPS). Cardiovasc Intervent Radiol. 2012;35:1295\u2013300.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1599_CR15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/sj.bmt.1702386","volume":"25","author":"D Azoulay","year":"2000","unstructured":"Azoulay D, Castaing D, Lemoine A, Hargreaves GM, Bismuth H. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation. Bone Marrow Transplant. 2000;25:987\u201392.","journal-title":"Bone Marrow Transplant"},{"key":"1599_CR16","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/hep.510240321","volume":"24","author":"MW Fried","year":"1996","unstructured":"Fried MW, Connaghan DG, Sharma S, Martin LG, Devine S, Holland K, et al. Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation. Hepatology. 1996;24:588\u201391.","journal-title":"Hepatology"},{"key":"1599_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1034\/j.1600-0676.2001.210105.x","volume":"21","author":"T Zenz","year":"2001","unstructured":"Zenz T, R\u00f6ssle M, Bertz H, Siegerstetter V, Ochs A, Finke J. Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation\u2014role of transjugular intrahepatic portosystemic shunt (TIPS). Liver. 2001;21:31\u20136.","journal-title":"Liver"},{"key":"1599_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","volume":"16","author":"JA Coppell","year":"2010","unstructured":"Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant. 2010;16:157\u201368.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1599_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1053\/jlts.2001.0070154","volume":"7","author":"P Rajvanshi","year":"2001","unstructured":"Rajvanshi P, McDonald GB. Expanding the use of transjugular intrahepatic portosystemic shunts for veno-occlusive disease. Liver Transpl. 2001;7:154\u20137.","journal-title":"Liver Transpl"},{"key":"1599_CR20","doi-asserted-by":"publisher","first-page":"e942","DOI":"10.1097\/MD.0000000000000942","volume":"94","author":"X Wang","year":"2015","unstructured":"Wang X, Qi X, Guo X. Tusanqi-related sinusoidal obstruction syndrome in China: a systematic review of the literatures. Medicine. 2015;94:e942.","journal-title":"Medicine"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-01599-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-021-01599-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-01599-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T12:03:35Z","timestamp":1610280215000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-021-01599-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,10]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1599"],"URL":"https:\/\/doi.org\/10.1186\/s12876-021-01599-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-36169\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-36169\/v2","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,10]]},"assertion":[{"value":"15 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology (IORG No: IORG0003571). All patients had signed informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}